[1. TUMGOR G. Cirrhosis and hepatopulmonary syndrome. World J Gastroenterol. 2014; 20(10):2586-94.10.3748/wjg.v20.i10.2586394926724627594]Search in Google Scholar
[2. RAEVENS S., GEERTS A., STEENKISTE CV., VERHELST X., VLIERBERGHE HV., COLLE I. Hepatopulmonary syndrome and portopulmonary hypertension: recent knowledge in pathogenesis and overview of clinical assessment. Liver Int. 2015:1478-3223.10.1111/liv.1279125627425]Search in Google Scholar
[3. FRITZ JS., FALLON MB., KAWUT SM. Pulmonary vascular complications of liver disease. Am J RespirCrit Care Med. 2013; 187:133-43.10.1164/rccm.201209-1583CI357065723155142]Search in Google Scholar
[4. FALLON MB., ZHAN GJ. The lung in liver disease: old problem, new concepts. Trans Am Clin Climatol Assoc. 2013; 124: 250-62.]Search in Google Scholar
[5. SHAH R., MOUS AO., JOHN S. Hepatopulmonary syndrome: a rare diagnosis or missed entity. Q J Med. 2014; 107:565-66.10.1093/qjmed/hcu00324440926]Search in Google Scholar
[6. GRACE JA., ANGUS PW. Hepatopulmonary syndrome: update on recent advances in pathophysiology, investigation, and treatment. J Gastroenterol Hepatol. 2013; 28:213-910.1111/jgh.1206123190201]Search in Google Scholar
[7. KIM BJ., LEE SC., PARK SW., CHOI MS., KOH KC., PAIK SW., et al. Characteristics and prevalence of intrapulmonary shunt detected by contrast echocardiography with harmonic imaging in liver transplant candidates. Am J Cardiol. 2004; 94:525-8.10.1016/j.amjcard.2004.04.07415325947]Search in Google Scholar
[8. ZHANG J., FALLON MB. Hepatopulmonary syndrome: update on pathogenesis and clinical features. Nat Rev Gastroenterol Hepatol. 2012; 9(9):539-49.10.1038/nrgastro.2012.12322751459]Search in Google Scholar
[9. FENG G., RONG H. The role of hemodynamic and vasoactive substances on hepatopulmonary syndrome. 2014; 18:380-86.]Search in Google Scholar
[10. KOCH DG., BOGATKEVICH G., RAMSHESH V., LEMASTERS JJ., UFLACKER R., REUBEN A. Elevated levels of endothelin-1 in hepatic venous blood are associated with intrapulmonary vasodilatation in humans. Dig Dis Sci 2012; 57:516-23.10.1007/s10620-011-1905-6454786221964742]Search in Google Scholar
[11. THENAPPAN T., GOEL A., MARSBOOM G., FANG YH., TOTH PT., ZHANG HJ., et al. A central role for CD68(+) macrophages in hepatopulmonary syndrome reversal by macrophage depletion. Am J Respir Crit Care Med. 2011; 183:1080-91.10.1164/rccm.201008-1303OC308674521148721]Search in Google Scholar
[12. ROBERTS KE., KAWUTS M., KROWKA MJ., BROWN RS., TROTTER JF., SHAH V., et al. Genetic risk factors for hepatopulmonary syndrome in patients with advanced liver disease. Gastroenterology. 2010; 139:130-9.10.1053/j.gastro.2010.03.044290826120346360]Search in Google Scholar
[13. MELO-SILVA CA., GAIOE., TREVIZOLI JE., SOUZA CS., GONCALVES AS., SOUSA GC., et al. Respiratory mechanics and lung tissue remodeling in a hepatopulmonary syndrome rat model. Respir Physiol Neurobiol. 2011; 179:326-33.10.1016/j.resp.2011.10.00122005255]Search in Google Scholar
[14. NACIF LS., ANDRAUS W., PINHEIRO RS., DUCATTI L., HADDAD LBP., D’ ALBUQUERQUE LC. The hepatopulmonary syndrome. Arq Bras Cir Dig. 2014; 27(2):145-7.10.1590/S0102-67202014000200012]Search in Google Scholar
[15. MACHICAO VI., FALLON MB. Hepatopulmonary syndrome. Semin Respir Crit Care Med. 2012; 33(1):11-6.10.1055/s-0032-130173022447256]Search in Google Scholar
[16. SILVERIO AO., GUIMARAES DC., ELIAS LFQ., MILANEZ EO., NAVES S. Are the spider angiomas skin markers of hepatopulmonary syndrome? Arq Gastroenterol. 2013;50(3):175-178.10.1590/S0004-2803201300020003124322187]Search in Google Scholar
[17. LV Y., FAN D. Hepatopulmonary syndrome. Dig Dis Sci. 2015 Jul; 60(7):1914-23.10.1007/s10620-015-3593-025732713]Search in Google Scholar
[18. KHABBAZA JE., KRASUSKI RA., TONELLI AR. Intrapulmonary shunt confirmed by intracardiac echocardiography in the diagnosis of hepatopulmonary syndrome. Hepatology. 2013 October; 58(4):1514-15.10.1002/hep.26482409629023696309]Search in Google Scholar
[19. KROWKA MJ. Hepatopulmonary syndrome: monitoring at your fingertip. Dig Dis Sci. 2011Jun; 56(6):1599-600.10.1007/s10620-011-1675-121448697]Search in Google Scholar
[20. SUCEVEANU AI., MAZILU L., TOMESCO D., CIUFU N., PAREPA IR., SUCEVEANU AP. Screening of hepatopulmonary syndrome (HPS) with CEUS and pulse-oximetry in liver cirrhosis patients eligible for liver transplant. Chirurgia. 2013; 108(5): 684-688.]Search in Google Scholar
[21. SILVA HM., REIAS G., GUEDES M., CLETO E., VIZCAINO JR., GENNERY AR., et al. A case of hepatopulmonary syndrome solved by mycophenolate mofetil (an inhibitor of angiogenesis and nitric oxide production). J Hepatol. 2013; 58:630-33.10.1016/j.jhep.2012.10.02123104163]Search in Google Scholar
[22. ESRAGHIAN A., KAMYAB AA., KEW-YOON S. Pharmacological treatment for hepatopulmonary syndrome. Biomed Res Int. 2013.10.1155/2013/670139378653624102057]Search in Google Scholar
[23. WALLACE MC., JAMES AL., MARSHALL M., KONTORINIS N. Resolution of severe hepatopulmonary syndrome following transjugular portosystemic shunt procedure. BMJ Case Reports. 2012.10.1136/bcr.02.2012.5811454315822669921]Search in Google Scholar
[24. ENACHE I., OSWALD-MAMMOSSER M., WOEHL-JAEGLE ML., HABERSETZER F., DI MARCO P., CHARLOUX A., et al. Cirrhotic cardiomyopathy and hepatopulmonary syndrome: prevalence and prognosis in a series of patients. Respir Med. 2013; 107:1030-36.10.1016/j.rmed.2013.03.010]Search in Google Scholar
[25. GUPTA S., CASTEL H., RAO RV., PICARD M., LILLY L., FAUGHNAN ME., et al. Improved survival after liver transplantation in patients with hepatopulmonary syndrome. Am J Transplant. 2010; 10:354-63.10.1111/j.1600-6143.2009.02822.x]Search in Google Scholar
[26. PASCASIO JM., GRILO I., LOPEZ-PARDO FJ., ORTEGA-RUIZ., TIRADO JL., SOUSA JM. Prevalence and severity of hepatopulmonary syndrome and its influence on survival in cirrhotic patients evaluated for liver transplantation. Am J Tranpl. 2014; 14: 1391-99.10.1111/ajt.12713]Search in Google Scholar
[27. YUICHI C., EGAWA H., TSUBOI T., OGA T. HONDA T., YAMAMOTO K., et al. Immediate noninvasive ventilation may improve mortality in patients with hepatopulmonary syndrome after liver transplantation. Liver Transpl. 2011; 17:144-48.10.1002/lt.22207]Search in Google Scholar
[28. MONSEL A., MAL H., BRISSON H., LUO R., EYRAUD D., VEZINET C., et al. Extracorporeal membrane oxygenation as a bridge to liver transplantation for acute respiratory distress syndrome-induced life threatening hypoxemia aggravated by hepatopulmonary syndrome. Crit Car. 2011; 15: R234.10.1186/cc10476]Search in Google Scholar
[29. AUZINGER G., WILLARS C., LOVERIDGE R., BEST T., VERCUEIL A., PRACHALIAS A., et al. Extracorporeal membrane oxygenation for refractory hypoxemia after liver transplantation in severe hepatopulmonary syndrome: a solution with pitfalls. Liver Transpl. 2014; 20:1141-1144.10.1002/lt.23926]Search in Google Scholar
[30. GOLDBERG DS., KROK K., BATRA S., TROTTER JF., KAWUT SM., FALLON MB. Impact of the hepatopulmonary syndrome MELD exception policy on outcomes of patients after liver transplantation: an analysis of UNOS database. Gastroenterology. 2014 May; 146(5) 1256-65.10.1053/j.gastro.2014.01.005]Search in Google Scholar
[31. AGUILAR MP., GALLEGOS-OROZCO JF. Hepatopulmonary syndrome: is it time to redefine the MELD exception score for better organ allocation and outcomes? Ann Hepatol. 2014; 13(4):468-70.10.1016/S1665-2681(19)30857-9]Search in Google Scholar
[32. NAYYAR D., MAN HSJ., GRANTON J., GUPTA S. Defining and characterizing severe hypoxemia after liver transplantation in hepatopulmonary syndrome. Liver Transpl. 2014; 20(2): 182-9010.1002/lt.2377624142412]Search in Google Scholar